Dr Max Taquet, Clinical Lecturer at the University of Oxford and senior author of the study, added: Our study is observational and these results should therefore be replicated in a randomised controlled trial to confirm and extend our findings. Nevertheless, they are good news for patients with psychiatric disorders, who are at an increased risk of diabetes. While semaglutide is also used in people with obesity, with most diabetes patients with type 2 diabetes also presenting being overweight or obese, the findings from this study cannot be applied to people who do not have diabetes.
New to MyHealth
We ensure that candidates do not have contraindications, such as a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, to minimize potential risks associated with the medication
Potential Cons of Carnitine The main con related to L-Carnitine supplementation is how its marketed, ;eading to confusion surrounding its use
Integrating ReadyRx - GLP-1 into Your Daily Meal Routines Optimal Timing and Meal Integration Successfully integrating ReadyRx - GLP-1 into daily meal routines requires strategic timing to maximize metabolic support benefits
Can you skip Wegovy doses on vacation